Neurotization of the Nipple Areolar Complex to Restore Sensation for Patients With Breast Cancer Undergoing Nipple Sparing Mastectomy and Reconstruction

Trial statusRecruiting
Trial phasePhase 2
Trial typeInterventional
Biological sexFemale
Age18+
SponsorMayo Clinic

About this trial

This phase II trial tests the willingness of patients undergoing nipple sparing mastectomy (NSM) to enroll in a randomized study of NSM with or without neurotization of the nipple areolar complex (NAC). This trial also compares patient reported outcomes, including quality of life and breast and NAC sexual functionality, for patients undergoing NSM with or without neurotization of the NAC. NSM is a standard practice option for patients undergoing preventative mastectomy, but many report dissatisfaction with decreased nipple sensation. Neurotization is a surgical technique using a nerve graft in an attempt to restore NAC sensation. Neurotization during NSM and reconstruction may restore NAC sensation and improve quality of life in breast cancer patients.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Female patients age >= 18

Eastern Cooperative Oncology Group (ECOG) performance status of 0, 1, or 2

Planned nipple sparing mastectomy (NSM)

Cup size A-C

Disqualifiers

Planned autologous reconstruction (immediate or delayed)

Pregnancy

Trial design

Design model

Parallel

Treatments tested in this trial

  • Neurotization Procedure

    Procedure/Surgery

    Undergo placement of nerve graft

  • Questionnaire Administration

    Other intervention

    Ancillary studies

  • Subcutaneous Mastectomy

    Procedure/Surgery

    Undergo standard of care NSM

Treatment groups

45 Participants
are divided into 2 treatment groups
Group A: ARM I (control)Active comparator 2 interventions
Group B: ARM II (neurotization)Experimental treatment 3 interventions

Trial outcomes

Primary outcomes

1

Percentage of patients undergoing nipple sparing mastectomy (NSM) to enroll in a randomized trial of NSM with or without neurotization

Will calculate the proportion of eligible patients who opt to take part in the study. Additionally, will descriptively analyze and report the specific factors that influenced patients' decisions to participate, with the aim of identifying and addressing any obstacles encountered.

Time frame
Up to 2 years

Secondary outcomes

1

Chest physical well-being

Measured using the BREAST-Q© scored on a 3-point Likert scale where 1=None of the time and 3=All of the time. Higher scores indicate poorer chest physical well-being.

Time frame
At baseline and up to 12 months
2

Psychosocial well-being

Measured using the BREAST-Q© scored on a 5-point Likert scale where 1=None of the time and 5=All of the time. Higher scores indicate poorer psychosocial well-being.

Time frame
At baseline and up to 12 months
3

Sexual well-being

Measured using the BREAST-Q© scored on a 5-point Likert scale where 1=None of the time and 5=All of the time. Higher scores indicate poorer sexual well-being.

Time frame
At baseline and up to 12 months
4

Patient reported amount of sensation in nipple areolar complex (NAC) and breast

Patient reported amount of sensation in nipple areolar complex (NAC) and breast will be will be assessed using a 5-item sensation questionnaire with 5 options to answer each question. Examples of answers include a range from Very unpleasant to Very pleasant or Unimportant to Very Important. Results will be reported descriptively.

Time frame
At baseline and up to 12 months

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.